| Literature DB >> 33457135 |
Nupur Mishra1, Devyani Mohan2, Sehrish Fuad1, Deepak M Basavanagowda3, Zaid A Alrashid4, Arveen Kaur3, Bindu Rathod3, Sadia Nosher5, Stacey E Heindl1,6.
Abstract
Vascular dementia (VD) is one of the leading causes of dementia, and hypertension is a known risk factor for VD. Hypertension treatment guidelines have previously discussed an optimal blood pressure goal to prevent further cardiovascular complications with long-term management. The treatment of hypertension can prevent stroke, kidney failure, and perhaps prevent cognitive decline as well. We reviewed studies that demonstrated an association between hypertension and cognitive impairment (CI). The role of antihypertensive medications (AHM) in preventing CI was also investigated. This topic is worth exploring as dementia has high healthcare costs and will become prominent as the population in the United States ages. We used the medical subject heading (MeSH) search strategy on Pubmed and reviewed 22 articles. The studies showed that there might be a link between hypertension, AHM, and CI. The studies did not suggest a superiority of any specific AHM class to prevent CI. Further research on optimal hypertension treatment goals to prevent cognitive impairment and dementia is recommended.Entities:
Keywords: ace inhibitors; angiotensin receptor blockers; antihypertensive medications; blood pressure; calcium channel blockers; cognition; cognitive impairment; dementia; hypertension; thiazide diuretics
Year: 2020 PMID: 33457135 PMCID: PMC7797448 DOI: 10.7759/cureus.12035
Source DB: PubMed Journal: Cureus ISSN: 2168-8184